Search Within

Susan Slovin

Formats
  1. Journal Article (141)
  2. Meeting Abstract (90)
  3. Book Section (7)
  4. Editorial (7)
  5. Review (6)
  6. Conference Paper (2)
  7. Guidelines (1)
Groups
  1. Department of Medicine (254)
  2. Genitourinary Oncology Service (254)
  3. Hematologic Malignancies, Division of (254)
  4. Solid Tumor Oncology Division (254)
  5. GSK Faculty (66)
  6. Molecular Pharmacology and Chemistry Program Faculty (54)

More Groups

People
  1. Howard Scher (140)
  2. Michael Morris (90)
  3. Dana Rathkopf (59)
  4. Daniel Danila (39)
  5. William Kelly (31)
  6. Karen Autio (28)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
  3. 2023 (11)
  4. 2022 (7)
  5. 2021 (7)
  6. 2020 (13)

More Years

Publications
  1. Journal of Clinical Oncology (81)
  2. Clinical Cancer Research (20)
  3. Cancer (11)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (8)
  5. Seminars in Oncology (8)
  6. Annals of Oncology (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (84)
  2. American Association for Cancer Research (31)
  3. Elsevier Inc. (21)
  4. Elsevier Science, Inc. (14)
  5. Springer (12)
  6. Wiley Blackwell (12)

More Publishers

Results (254)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The men's cycle plus docetaxel (Doc) in prostate cancer patients with rising PSAs in the non-castrate state
    Meeting Abstract

    Slovin, S. F.; Carducci, M. A.; Beekman, K. W.; Pili, R.; Eicher, C.; Kelly, W. K.; Morris, M. J.; Shaffer, D.; Eisenberger, M.; Scher, H. I.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A phase I/II trial to assess tolerability and efficacy of RAD-001 with gefitinib in patients with glioblastoma multiforme and castrate metastatic prostate cancer
    Meeting Abstract

    Shaffer, D. R.; Abrey, L.; Beekman, K.; Morris, M.; Eicher, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Rosen, N.; Scher, H. I.
    EJC Supplements (2005)

    Fulltext@MSK | Save
  • Phase II study of boriezomib for castrate metastatic prostate cancer (PC)
    Meeting Abstract

    Morris, M. J.; Beekman, K. W.; Kelly, W. K.; Slovin, S. F.; Shaffer, D.; Eicher, C.; Chu, E.; Curley, T.; Delacruz, A.; Scher, H. I.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A synthetic peptide, PCK3145, for the treatment of hormone refractory prostate cancer
    Meeting Abstract

    Daigneault, L.; Panchal, C.; Scher, H. I.; Slovin, S. F.; Rabbani, S.; Dulude, H.; Garde, S.; Ruiz, M.; Wu, J.; Hawkins, R.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Time to detectable metastatic disease in patients with rising prostate-specific antigen values following surgery or radiation therapy
    Journal Article

    Slovin, S. F.; Wilton, A. S.; Heller, G.; Scher, H. I.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: Clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer
    Journal Article

    Slovin, S. F.; Ragupathi, G.; Musselli, C.; Fernandez, C.; Diani, M.; Verbel, D.; Danishefsky, S.; Livingston, P.; Scher, H. I.
    Cancer Immunology, Immunotherapy (2005)

    Fulltext@MSK | Save
  • A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: A study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 or QS-21
    Journal Article

    Slovin, S. F.; Ragupathi, G.; Fernandez, C.; Jefferson, M. P.; Diani, M.; Wilton, A. S.; Powell, S.; Spassova, M.; Reis, C.; Clausen, H.; more...
    Vaccine (2005)

    Fulltext@MSK | Save
  • Carbohydrate vaccines as immunotherapy for cancer
    Journal Article

    Slovin, S. F.; Keding, S. J.; Ragupathi, G.
    Immunology and Cell Biology (2005)

    Fulltext@MSK | Save
  • PSMA for use in renal and prostate cancer vaccines
    Journal Article

    Slovin, S. F.
    American Journal of Urology Review (2005)

    Fulltext@MSK | Save
  • Targeting novel antigens for prostate cancer treatment: Focus on prostate-specific membrane antigen
    Journal Article

    Slovin, S. F.
    Expert Opinion on Therapeutic Targets (2005)

    Fulltext@MSK | Save